Estrogen decline causes vaginal dryness, reduced sensitivity and slower arousal, but these treatable conditions shouldn't be accepted as inevitable aging. Underlying health issues like diabetes, cardiovascular disease, depression and medication side effects significantly impact sexual function in women over 50.
Sex After 50: How Women Can Maintain Pleasure Despite Hormonal Changes
Cobertura Relacionada
Pai das gêmeas unidas pela cabeça que morreram em cirurgia de separação agradece empenho de mais de 50 profissionais do …
Folha de S.Paulo · Aug 20 Selton Mello se emociona ao receber Kikito de Cristal em GramadoSelton Mello recebeu o Kikito de Cristal no Festival de Gramado e se emocionou ao lembrar que era a primeira vez receben…
G1 · Aug 20 CEMEI Amiguinhos da Vila inaugura prédio moderno com capacidade para 320 alunosInaugurado novo prédio do CEMEI Amiguinhos da Vila em Montes Claros, com capacidade para 320 alunos, oito salas de aula,…
Folha de S.Paulo · Aug 20 Hepatites D e E circulam no Brasil e preocupam especialistasRevisão de 200 estudos com dados de 14,5 milhões de pessoas revela que hepatites D e E circulam no Brasil com prevalênci…
Viés e Enquadramento
Não há dados de análise detalhada para esta lente. Tente executar as lentes novamente no painel de administração.
Impacto Geopolítico
This is a health/medical article about women's sexuality after 50, not a geopolitical matter. No international implications exist.
Lente Econômica
Healthcare article on menopausal women's sexual health has limited direct economic impact; primarily affects pharmaceutical and medical device sectors serving hormone replacement and intimate care products.
Increased awareness may drive demand for treatment options and intimate care products among women 50+, potentially increasing healthcare spending in this demographic; reduces stigma around discussing sexual health, potentially expanding addressable market for related products and services.
May influence healthcare coverage decisions regarding hormone replacement therapy and sexual health treatments; could prompt public health campaigns normalizing menopausal sexual health discussions; potential regulatory review of over-the-counter intimate care product claims.